A change in the day of use is acceptable as long as there is a minimum two-day interval between doses
Practice Areas Partner Brian Jasper Brian Jasper is a 2011 graduate of Mercer University School of Law in Macon, GA
Data collected from a randomized, placebo-controlled, double-blind trial of liraglutide 3.0 mg, in which nausea was the most frequent adverse event, showed that greater weight loss was associated with transient nausea and vomiting in participants with obesity but without diabetes [50]
95% CI, 1.06-1.19) with 1 year of interruption and 16% (RR = 1.16
This staggered approach gives your stomach lining, vagal nerve signaling, and enteric nervous system time to adjust to the medication's effects on motility without overwhelming your gastrointestinal tract
The FDA labeling is specific about these thresholds to ensure medication integrity